Literature DB >> 2003228

Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens.

D Raghavan1, B Pearson, W H Watt, H Mameghan, P Langdon, D Eisinger, R Wines.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2003228

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  2 in total

1.  Neoadjuvant chemotherapy should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer of the bladder (MIBC): A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process.

Authors:  Jo-An Seah; Normand Blais; Scott North; Yasmin Rahim; Dean Ruether; Peter C Black; Alexandre R Zlotta; Lori Wood; Srikala S Sridhar
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

2.  Vinblastine and erythromycin: an unrecognized serious drug interaction.

Authors:  S W Tobe; L L Siu; S A Jamal; K L Skorecki; G F Murphy; E Warner
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.